検索対象:     
報告書番号:
※ 半角英数字
 年 ~ 
 年
検索結果: 1 件中 1件目~1件目を表示
  • 1

発表形式

Initialising ...

選択項目を絞り込む

掲載資料名

Initialising ...

発表会議名

Initialising ...

筆頭著者名

Initialising ...

キーワード

Initialising ...

使用言語

Initialising ...

発行年

Initialising ...

開催年

Initialising ...

選択した検索結果をダウンロード

口頭

尿排泄性の高い$$^{111}$$In標識馬尿酸誘導体の合成と${it in vivo}$評価

鈴木 博元; 金井 彩香*; 上原 知也*; 花岡 宏史*; 荒野 泰*

no journal, , 

Radiolabeled antibody fragments show rapid elimination rate from blood, which can improve bone marrow toxicities of radiolabeled intact IgG. However, high and persistent localization in kidney is observed, which impairs diagnostic accuracy and therapeutic effectiveness. Brush border strategy succeeded to reduce renal radioactivity by using the radioiodine labeled antibody fragment in which a cleavable peptide linker is introduced. In the strategy, the radiometabolite is liberated by the action of renal brush border enzymes before incorporating into renal cells, and excreted into urine. In order to apply this molecular design to radiometals such as $$^{111}$$In and $$^{90}$$Y, the radiometabolite with high urinary excretion, which includes a radiometal-chelating moiety is required. In this study, we synthesized and evaluated a hippuric acid derivative, Bn-CHX-A"-DTPA-Gly labeled with $$^{111}$$In as a radiometabolite.

1 件中 1件目~1件目を表示
  • 1